Inhibitor Summit 2018
EHC Now! Third EHC Inhibitor Summit
In this week’s EHC Now! we give you a brief account of the EHC’s third Inhibitor Summit. From 6 to 9 December close to 150 people gathered in Barretstown, located an hour outside of...
2018 12 12 Inhibitor Summit FINAL3
Registration for the 2018 EHC Inhibitor Summit is now open
After the great success of the two previous Inhibitor Summits organised by the European Haemophilia Consortium (EHC), we are delighted to announce the third annual EHC Inhibitor Summit that will take place in Barretstown,...
Inhibitor summit 2017
Inhibitor summit 2017
Registrations are now open for the EHC first Inhibitor Summit
The European Haemophilia Consortium (EHC) will hold on 1-4 December 2016 its first Inhibitor Summit in Barretstown, Ireland. This event is aimed exclusively at representatives from EHC National Member Organisations (NMO) who have bleeding...
European Rare and Inhibitor Network
Background In 2015, the European Haemophilia Consortium launched a programme to cater for people with haemophilia that have inhibitors on a European level as the numbers of people with inhibitors nationally are often too...
Inhibitors
In this section we will provide more information on: Inhibitor formation Treatment options for people with inhibitors European Inhibitor Network People with bleeding disorders are treated with what is called replacement therapy....
Jim is aged 66 and has Haemophilia A with a high titer inhibitor which he developed at age 14.
Maria Elisa Mancuso (MD, PhD) is a Haematologist and works as a Senior Haematology Consultant at the Center for Thrombosis and Haemorrhagic Diseases of IRCCS Humanitas Research Hospital in Rozzano, Milan, Italy. She is Adjunct Clinical Professor at Humanitas University. She obtained a post-degree in Clinical and Experimental Haematology and a PhD in Clinical Methodology. She is involved in clinical research and has published several original articles in peer-reviewed journals a The Lancet, Blood, Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis and Haemostasis, British Journal of Haematology and Haemophilia. She is reviewer for several peer-reviewed journals and member of the Editorial Board of JTH. She is a member of several scientific societies (ISTH, WFH, ASH, EAHAD, SISET, AICE) and was a medical member of the Inhibitor Working Group of the European Hemophilia Consortium. She is co-chair of the ADVANCE Study Group. She has acted also as co-chair of the Scientific and Standardization Subcommittee of ISTH on FVIII, FIX and rare bleeding disorders. She has been involved as principal and co-investigator in several clinical trials, and she takes care of both children and adults with hemophilia and other congenital bleeding disorders with a specific scientific interest in novel therapies, prophylaxis, inhibitors, and chronic hepatitis C.
As a patient with factor II deficiency, the diagnostic and treatment of rare bleeding disorders is a matter dear to my heart. My motivation to participate in the work of the ERIN committee is to improve both diagnostic and treatment for patients with rare bleeding disorders across Europe.
Economist and financial expert by profession, executive coach and trainer by passion and haemophilia advocate by every drop of my blood through my son (who has severe haemophilia A with inhibitors). Bringing a good decade of practical experience from the corporate insurance world, laser focus, growth mindset and resilience from my own experience, offering you anything I can just do, in hope that together we can make life more fulfilled for those impacted by bleeding disorders.
Amy Owen-Wyard is a Registered Mental Health Nurse. With experience working with children, young people, their families and adults with severe and enduring mental health conditions. Amy was also involved in a service improvement to provide a holistic care approach for those in general hospitals to support both their mental and physical health, whilst sharing her expertise and knowledge in mental health with the wider multidisciplinary team.
